Enzymatica publ AB
Research Enzymatica publ AB (ENZY) on Bullrun: market cap SEK 609.27M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerENZY
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencySEK
- Market capSEK 609.27M
- Financial periodQ1 2026
- RevenueSEK 11.44M
- Net income-SEK 13.46M
- Free cash flow-SEK 6.83M
- Gross margin56.4%
Valuation Snapshot
latest market cap is SEK 609.27M.
About Enzymatica publ AB
Enzymatica AB (publ), a life science company, develops and sells medical devices for infectious diseases. The company's product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses that can cause cold and flu symptoms. It also provides enzyme formulations for skin care under Penzyme technology. The company was incorporated in 2007 and is headquartered in Lund, Sweden.
Frequently asked questions
What is Enzymatica publ AB's market cap?
Enzymatica publ AB's market capitalization is SEK 609.27M.
What does Enzymatica publ AB do?
Enzymatica AB (publ), a life science company, develops and sells medical devices for infectious diseases. The company's product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses that can cause cold and flu symptoms.